Michelle Lorimer
Papers
1
Total Citations
18
H-Index
1
About
Michelle Lorimer is a leading clinical researcher in orthopaedic surgery, with a primary focus on advancing total knee arthroplasty (TKA) through rigorous, registry-nested trials. Her most cited work, the RASKAL study protocol (2022, 18 citations), exemplifies her expertise in designing large-scale, multicentre randomised controlled trials that evaluate the combined and individual effects of robotic-assisted surgery (RAS) and kinematic alignment (KA) against computer-assisted surgery (CAS) and mechanical alignment. This protocol, nested within a national registry, addresses critical uncertainty in modern knee replacement, aiming to clarify whether these emerging technologies truly improve clinical, functional, radiographic, and survivorship outcomes. Lorimer’s contributions are pivotal in moving the field toward evidence-based adoption of surgical innovations. Her work directly impacts surgeons and patients by providing high-quality data on intraoperative precision and long-term implant survival. Through the RASKAL trial, she is shaping the future of TKA, ensuring that technological advances are validated by robust science. Her research is essential reading for orthopaedic trainees and researchers seeking to understand the next frontier in joint replacement.
Research Focus
Key Achievements
Top Papers
- 1